DK1216047T3 - Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma - Google Patents

Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma

Info

Publication number
DK1216047T3
DK1216047T3 DK00969304T DK00969304T DK1216047T3 DK 1216047 T3 DK1216047 T3 DK 1216047T3 DK 00969304 T DK00969304 T DK 00969304T DK 00969304 T DK00969304 T DK 00969304T DK 1216047 T3 DK1216047 T3 DK 1216047T3
Authority
DK
Denmark
Prior art keywords
loteprednol
inhalation
beta
combination
bronchial asthma
Prior art date
Application number
DK00969304T
Other languages
English (en)
Inventor
Istvan Szelenyi
Sabine Heer
J Rgen Engel
Hildegard Poppe
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK1216047T3 publication Critical patent/DK1216047T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DK00969304T 1999-09-30 2000-09-26 Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma DK1216047T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19947235A DE19947235A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten

Publications (1)

Publication Number Publication Date
DK1216047T3 true DK1216047T3 (da) 2006-02-13

Family

ID=7924101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969304T DK1216047T3 (da) 1999-09-30 2000-09-26 Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma

Country Status (20)

Country Link
US (1) US7521438B1 (da)
EP (1) EP1216047B1 (da)
JP (1) JP5068912B2 (da)
AR (1) AR025924A1 (da)
AT (1) ATE306271T1 (da)
AU (1) AU7907400A (da)
BR (1) BR0014374B1 (da)
CA (1) CA2389111C (da)
CY (1) CY1105548T1 (da)
CZ (1) CZ296396B6 (da)
DE (2) DE19947235A1 (da)
DK (1) DK1216047T3 (da)
EE (1) EE05050B1 (da)
ES (1) ES2248131T3 (da)
HU (1) HUP0202753A3 (da)
MX (1) MXPA02003329A (da)
PL (1) PL196729B1 (da)
SI (1) SI1216047T1 (da)
TW (1) TWI253930B (da)
WO (1) WO2001022956A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2005041980A1 (en) * 2003-11-03 2005-05-12 Ivax Corporation Soft steroid compositions for use in dry powder inhalers
EP2221048A1 (en) 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
US9238144B2 (en) * 2013-03-14 2016-01-19 Neuropace, Inc. Optimizing data retrieval from an active implantable medical device
WO2022016150A1 (en) * 2020-07-17 2022-01-20 Ross Peter M Methods for the treatment of cytokine release syndromes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB416950A (en) * 1933-07-28 1934-09-25 Ambrose Heal An improved support member for beds, settees, wardrobes and other articles of furniture
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
ZA814440B (en) * 1980-07-10 1982-10-27 Otsuka Pharma Co Ltd Soft steroids having anti-inflammatory activity
TW503113B (en) * 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
WO1998034595A1 (de) * 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US5830490A (en) * 1997-04-04 1998-11-03 Weinstein; Robert E. Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders
EP1862164A3 (de) 1998-11-13 2012-12-26 Jagotec AG Trockenpulver zur Inhalation

Also Published As

Publication number Publication date
PL353487A1 (en) 2003-11-17
EE200200163A (et) 2003-04-15
EP1216047A2 (de) 2002-06-26
CA2389111C (en) 2009-04-14
DE19947235A1 (de) 2001-04-05
BR0014374B1 (pt) 2012-12-25
PL196729B1 (pl) 2008-01-31
CA2389111A1 (en) 2001-04-05
HUP0202753A2 (hu) 2002-12-28
ATE306271T1 (de) 2005-10-15
WO2001022956A3 (de) 2001-10-11
AU7907400A (en) 2001-04-30
EE05050B1 (et) 2008-08-15
JP5068912B2 (ja) 2012-11-07
SI1216047T1 (sl) 2006-02-28
AR025924A1 (es) 2002-12-18
BR0014374A (pt) 2002-06-25
JP2003510276A (ja) 2003-03-18
DE50011340D1 (de) 2006-02-23
CZ296396B6 (cs) 2006-03-15
CY1105548T1 (el) 2010-07-28
TWI253930B (en) 2006-05-01
ES2248131T3 (es) 2006-03-16
HUP0202753A3 (en) 2004-06-28
US7521438B1 (en) 2009-04-21
WO2001022956A2 (de) 2001-04-05
MXPA02003329A (es) 2004-09-10
CZ20021095A3 (cs) 2002-08-14
EP1216047B1 (de) 2005-10-12

Similar Documents

Publication Publication Date Title
BRPI0513866A (pt) composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
EP1796625A4 (en) NOVEL FENOFIBRATE FORMULATIONS AND METHODS OF TREATMENT RELATING THERETO
IL163278A (en) Formulations including glp-1 compounds and their use in drug preparation
PL352385A1 (en) Replication inhibitors of syncytial respiratory viruses
FI20010540A0 (fi) Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö
DK1183029T3 (da) Farmaceutisk præparat indeholdende diamorfin og vitamin E og dets anvendelse til behandling af opiatmisbrug
PL352378A1 (en) Replication inhibitors of syncytial respiratory virus
DK66493D0 (da) Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
NO20051942D0 (no) Substituerte 4-cindazol-3-yl)fenoler som ostrogenreseptor-(ER) ligander og deres anvendelse ved behandling av inflammatoriske sykdommer
IL182222A0 (en) Treatment of bipolar disorders and associated symptoms
DK1216047T3 (da) Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma
EP1377611A4 (en) MUTINES OF THE HYPOXIC INDUCIBLE FACTOR ALPHA AND METHOD OF USE THEREOF
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
HK1175117A1 (en) Composition and method for the treatment of asthma symptoms
EP1694694A4 (en) REPLICATION COMPETENT HEPATITIS C-VIRUS AND METHOD OF USE
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
IL165378A0 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
EP1478438A4 (en) TECHNIQUES AND COMPOSITIONS FOR THE TREATMENT OF ASTHMA AND RELATED DISORDERS
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20030295L (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
MXPA03003592A (es) Uso de la tolerancia en el tratamiento del asma.
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
EP1546377A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING MOLECULES 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 OR 13424